Solving the Enigma: A machine that finds drugs faster

UL spinout firm Bio Hooke has found a way to improve the drug discovery process

Dr Finola Cliffe, chief operations officer; Dr Mark Lyons, chief executive officer; Prof Mark Davies, founder of Hooke Bio with Enigma drug discovery platform

Dr Finola Cliffe, chief operations officer; Dr Mark Lyons, chief executive officer; Prof Mark Davies, founder of Hooke Bio with Enigma drug discovery platform

The Enigma machine cracked enemy codes during the war. Now a new machine with the same name is set to break the mould in drug development.

University of Limerick spinout Hooke Bio has its sights set on disrupting the process of drug discovery. In a nutshell, Hooke has developed a platform that runs screening tests 20 times faster and at a quarter of the cost of current commercial systems. This will be music to the ears of drug companies that run millions of tests a year to explore and test the feasibility of potential new drug combinations.

Please subscribe or sign in to continue reading.
only €1 first month

Insightful opinion is just a away.